Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Rigel on the slide as asthma drug falls over

Share plummet after phase II failure of R343

- PMLiVE

Eisai launches online obesity awareness drive

Wants US employers to realise the cost of obesity

- PMLiVE

Why client satisfaction is not enough

Perhaps a client is satisfied with the service you provide, but is he committed to it?

- PMLiVE

Jutta Heim joins Nuevolution

Takes role as director and scientific advisor at Danish discovery company

Shire extends rare genetic disease alliance

Agrees option with Santaris to nominate additional discovery targets

- PMLiVE

Amgen and Onyx agree $10.4bn takeover deal

Deal provides indication of the premium big biopharma will pay to replenish pipelines

- PMLiVE

AZ adds to pipeline again with Amplimmune buy

Pharma company pays $500m via its MedImmune subsidiary for the small US biotech

- PMLiVE

Internis appoints Sandoz’s Paul Tredwell

He joins the UK bone disorder-focused start-up as chief operating officer

- PMLiVE

UK market access: The importance of a local value story

Meeting the needs of the health service’s new stakeholders

- PMLiVE

Upwardly mobile: Pharma opportunities in mHealth

mHealth presents a major opportunity for the pharmaceutical industry, but mobile is not about being remote, it’s about being connected and to progress, pharma needs to be better connected with...

Takeda expands Latin American footprint

Opens new subsidiary in Peru

- PMLiVE

Phase III data raise hopes for Takeda’s vedolizumab

Bowel disease drug shows efficacy in ulcerative colitis and Crohn's disease

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links